Compare FSEA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSEA | DXR |
|---|---|---|
| Founded | 1890 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7M | 59.0M |
| IPO Year | 2022 | 1995 |
| Metric | FSEA | DXR |
|---|---|---|
| Price | $16.71 | $10.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 72.4K | 8.6K |
| Earning Date | 05-12-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.13 | $7.73 |
| 52 Week High | $16.80 | $14.76 |
| Indicator | FSEA | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 77.26 | 53.38 |
| Support Level | $16.60 | $9.11 |
| Resistance Level | $16.80 | $11.23 |
| Average True Range (ATR) | 0.07 | 0.70 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 55.00 | 55.13 |
First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.